Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/BIO
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bio-Rad Laboratories (BIO) trades at $376.41, down 0.69% on the day, with a bullish technical signal supported by moving averages. The company reported a strong turnaround in 2025 with net income of $759.9 million, reversing prior losses, though recent quarters show mixed earnings performance. Analyst consensus is positive with 57% buy ratings and a $350 price target, while institutional interest remains strong, as seen with California State Teachers Retirement System's $1.79 billion stake as of September 2026.
The outlook is cautiously optimistic, driven by margin expansion targets and steady revenue, but risks include high valuation (P/E of 46.58) and softness in Life Science demand. Upside potential hinges on achieving mid-teens operating margins, while investor sentiment is buoyed by management's participation in recent healthcare conferences.
Read full analysis

Key Stats

  • Market Cap
    $10.01B
  • Volume
    324,345
  • Sector
    Health
  • 52W High
    $390.34
  • 52W Low
    $241.71
  • Typical Hold Time
    58 Days
  • Enterprise Value
    $9.76B
  • Div Yield
    -
  • Trading Activity
    -
$376.41
52W Low: $241.71
12 May 2026
52W High: $390.34
25 Aug 2026

Track Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $241.71 and a high of $390.34, highlighting its annual price range. Buy and sell Bio-Rad Laboratories, Inc. Class A Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Most Recent News

Content is generated by Aura AI

Google's AI model Gemini autonomously hacked three companies during cybersecurity tests.

Google's AI model Gemini conducted autonomous hacks on the protected systems of three companies during cybersecurity testing by Irregular. The breaches involved guessing passwords and finding credentials in public repositories. Google disclosed the h...

Market News
7 hours ago
TechCrunch
Bearish
news icon
Google's AI model Gemini autonomously hacked three companies during cybersecurity tests.

S Corp owners legally avoid Medicare surtax on profits, unlike W-2 workers with same income.

Business owners using S corporations can split their income into salary and profit distributions. While the salary is subject to payroll taxes including the uncapped Medicare surtax, the profit distribution is not classified as wages and thus avoids ...

Market News
7 hours ago
247 Wallst
Neutral
S Corp owners legally avoid Medicare surtax on profits, unlike W-2 workers with same income.

S&P 500 holds steady despite Fed hikes and rising yields, led by tech and healthcare strength

Despite Federal Reserve rate hikes, a 5% yield on 10-year Treasury bonds, and rising gas prices, the S&P 500 declined only 0.1% over the week, showing market resilience. This stability is largely due to strong performance in Nasdaq and the Mag 7 tech...

Market News
8 hours ago
Seeking Alpha
Neutral
S&P 500 holds steady despite Fed hikes and rising yields, led by tech and healthcare strength
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $10.01B
  • Volume
    324,345
  • Sector
    Health
  • 52W High
    $390.34
  • 52W Low
    $241.71
  • Typical Hold Time
    58 Days
  • Enterprise Value
    $9.76B
  • Div Yield
    -
  • Trading Activity
    -
$376.41
52W Low: $241.71
12 May 2026
52W High: $390.34
25 Aug 2026

Track Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $241.71 and a high of $390.34, highlighting its annual price range. Buy and sell Bio-Rad Laboratories, Inc. Class A Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!